Overview
Yongjian Liu practices practicing medicine in Dalian, China.
Their clinical expertise encompasses Cerebral Hypoxia, Glioblastoma, Astrocytoma, and Glioma.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yongjian Liu
Is Yongjian Liu a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Yongjian Liu is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yongjian Liu participate in research or clinical trials?
Yes. Yongjian Liu has published 11 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Yongjian Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaLiu isExperienced. Learn about Astrocytoma.
- Cerebral HypoxiaLiu isExperienced. Learn about Cerebral Hypoxia.
- GlioblastomaLiu isExperienced. Learn about Glioblastoma.
- GliomaLiu isExperienced. Learn about Glioma.
- Gliomatosis CerebriLiu isExperienced. Learn about Gliomatosis Cerebri.